OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	76
TREM-2: friend or foe in infectious diseases?	74
Salmonella in eggs and egg-laying chickens: pathways to effective control	64
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	49
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	48
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	46
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	41
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	36
Current and emerging therapies for fungal biofilms and systemic infections	35
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	34
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	33
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	33
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses	29
LysR-type transcriptional regulators: state of the art	28
Exploring halophilic environments as a source of new antibiotics	28
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	27
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	26
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread	25
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	24
Vibrio cholerae virulence and its suppression through the quorum-sensing system	24
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	23
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties	23

Polyamine as a microenvironment factor in resistance to antibiotics	23
Bacterial vaginosis: advancing insights into microbial dysbiosis	22
The diffusible signaling factor family in microbial signaling: a current perspective	20
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	20
Building up a clinical microbiota profiling: a quality framework proposal	19
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	18
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	17
Phage-bacterial evolutionary interactions: experimental models and complications	17
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	17
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	17
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	16
Microbial persisters and host: recent advances and future perspectives	16
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	15
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	15
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	14
Advances in mining and expressing microbial biosynthetic gene clusters	14
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	14
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	13
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	13
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	13
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	13
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	13
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	12
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	12
Aspergilli series Versicolores: importance of species identification in the clinical setting	12
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	12
The crosstalk between SUMOylation and immune system in host-pathogen interactions	11
Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans	11
Anti-virulence peptides: a compromising strategy to treat Staphylococcus aureus chronic wound infection	11
Antibiotic resistance genes in Escherichia coli – literature review	11
Genetic basis of antibiotic resistance in bovine mastitis and its possible implications for human and ecological health	11
Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa	11
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	11